• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, July 5, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

A sarbecovirus found in Russian bats is capable of using human ACE2 to enter cells, and is resistant to the antibodies of people vaccinated against SARS-CoV-2

Bioengineer by Bioengineer
September 22, 2022
in Health
Reading Time: 2 mins read
0
A sarbecovirus found in Russian bats is capable of using human ACE2 to enter cells, and is resistant to the antibodies of people vaccinated against SARS-CoV-2
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A sarbecovirus found in Russian bats is capable of using human ACE2 to enter cells, and is resistant to the antibodies of people vaccinated against SARS-CoV-2

A sarbecovirus found in Russian bats is capable of using human ACE2 to enter cells, and is resistant to the antibodies of people vaccinated against SARS-CoV-2

Credit: João Manuel Lemos Lima, Wikimedia Commons (CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

A sarbecovirus found in Russian bats is capable of using human ACE2 to enter cells, and is resistant to the antibodies of people vaccinated against SARS-CoV-2

 

Article URL: http://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1010828

Article Title: An ACE2-dependent Sarbecovirus in Russian bats is resistant to SARS-CoV-2 vaccines

Author Countries: United States

Funding: This work was supported by WSU and the Paul G. Allen School for Global Health (ML BG, SNS, SF, SB). Funding for the clinical study specimens was provided under NIH Project U54CA260581-01 (JR, KZ, EN) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.



Journal

PLoS Pathogens

DOI

10.1371/journal.ppat.1010828

Method of Research

Experimental study

Subject of Research

Cells

COI Statement

Competing Interests: The authors have declared that no competing interests exist.

Share12Tweet8Share2ShareShareShare2

Related Posts

Lysine Pyruvylation Links Glycolysis to Epigenetics

July 4, 2026

Personalized Neoantigen Dendritic Cell Vaccine in Glioblastoma

July 4, 2026

Decoding Neural Timescales: A Computational Viewpoint

July 4, 2026

Uncovering C5aR2: Unique Signaling and Agonists

July 4, 2026

POPULAR NEWS

  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • Saying Goodbye to PGY-6: Pediatric Fellowship Realities

    103 shares
    Share 41 Tweet 26
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15
  • KTU Researchers Explore Ultrasound’s Role in Enhancing Blood Flow Beyond Diagnostics

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Quasi-Bound States Boost Quantum Well Photoresponse

Lysine Pyruvylation Links Glycolysis to Epigenetics

Multiphysics Coupling: Single vs. Multiple DeepONet Branches

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 83 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.